Novo Nordisk to Lay Off 300 Employees
SOURCENews reportView the filing ↗
What we know
Location: United States.
A specific layoff date has not been disclosed.
Based on news reporting.
Summary
Novo Nordisk has announced plans to cut approximately 300 jobs in the United States as part of a strategic move to adapt to the competitive landscape of weight-loss drugs. This decision comes amid increasing pressure from rivals in the pharmaceutical industry. The layoffs are part of a broader restructuring effort aimed at maintaining the company's market position. Specific details regarding the timeline for these job cuts have not been disclosed, but the company is actively working to implement these changes. The layoffs reflect the challenges faced by Novo Nordisk in a rapidly evolving market.
LayoffTalk has tracked 28 layoff events at Novo Nordisk since October 2023, including 811 jobs documented in official WARN filings, with 27 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Estimated figure based on news reporting. Not yet confirmed by Novo Nordisk.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Novo Nordisk
Recent tracked events at this company.